U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Cutaneous amyloidosis(PLCA)

MedGen UID:
120635
Concept ID:
C0268397
Disease or Syndrome
Synonyms: Amyloidosis primary cutaneous; PLCA; Primary localized cutaneous amyloidosis
SNOMED CT: Primary localized cutaneous amyloidosis (733729003)
Modes of inheritance:
Autosomal dominant inheritance
MedGen UID:
141047
Concept ID:
C0443147
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele.
Not genetically inherited
MedGen UID:
988794
Concept ID:
CN307044
Finding
Source: Orphanet
clinical entity without genetic inheritance.
 
HPO: HP:0012309
Monarch Initiative: MONDO:0015301
Orphanet: ORPHA137807

Definition

Primary localized cutaneous amyloidosis is characterized clinically by pruritus and skin scratching and histologically by the finding of deposits of amyloid staining on keratinous debris in the papillary dermis (summary by Tanaka et al., 2009). Genetic Heterogeneity of Primary Localized Cutaneous Amyloidosis Primary localized cutaneous amyloidosis-2 (PLCA2; 613955) is caused by heterozygous mutation in the IL31RA gene (609510) on chromosome 5q11. Primary localized cutaneous amyloidosis-3 (PLCA3; 617920) is caused by mutation in the GPNMB gene (604368) on chromosome 7p15. [from OMIM]

Conditions with this feature

X-linked reticulate pigmentary disorder
MedGen UID:
336844
Concept ID:
C1845050
Disease or Syndrome
X-linked reticulate pigmentary disorder shows more severe manifestations in hemizygous males compared to heterozygous females. Affected males have early onset of recurrent respiratory infections and failure to thrive resulting from inflammatory gastroenteritis or colitis. Patients also show reticular pigmentation abnormalities of the skin and may develop corneal scarring. Carrier females may be unaffected or have only pigmentary abnormalities along the lines of Blaschko (summary by Starokadomskyy et al., 2016).
Amyloidosis, primary localized cutaneous, 2
MedGen UID:
462754
Concept ID:
C3151404
Disease or Syndrome
Primary localized cutaneous amyloidosis is characterized clinically by pruritus and skin scratching and histologically by the finding of deposits of amyloid staining on keratinous debris in the papillary dermis (summary by Tanaka et al., 2009). For a general description and a discussion of genetic heterogeneity of PLCA, see 105250.
Amyloidosis, primary localized cutaneous, 1
MedGen UID:
1639046
Concept ID:
C4551501
Disease or Syndrome
In some affected individuals, the patches have characteristics of both lichen and macular amyloidosis. These cases are called biphasic amyloidosis.\n\nNodular amyloidosis is characterized by firm, raised bumps (nodules) that are pink, red, or brown. These nodules often occur on the face, torso, limbs, or genitals and are typically not itchy.\n\nIn macular amyloidosis, the patches are flat and dark brown. The coloring can have a lacy (reticulated) or rippled appearance, although it is often uniform. Macular amyloidosis patches are most commonly found on the upper back, but they can also occur on other parts of the torso or on the limbs. These patches are mildly itchy.\n\nIn all forms of PLCA, the abnormal patches of skin usually arise in mid-adulthood. They can remain for months to years and may recur after disappearing, either at the same location or elsewhere. Very rarely, nodular amyloidosis progresses to a life-threatening condition called systemic amyloidosis, in which amyloid deposits accumulate in tissues and organs throughout the body.\n\nLichen amyloidosis is characterized by severely itchy patches of thickened skin with multiple small bumps. The patches are scaly and reddish brown in color. These patches usually occur on the shins but can also occur on the forearms, other parts of the legs, and elsewhere on the body.\n\nPrimary localized cutaneous amyloidosis (PLCA) is a condition in which clumps of abnormal proteins called amyloids build up in the skin, specifically in the wave-like projections (dermal papillae) between the top two layers of skin (the dermis and the epidermis). The primary feature of PLCA is patches of skin with abnormal texture or color. The appearance of these patches defines three forms of the condition: lichen amyloidosis, macular amyloidosis, and nodular amyloidosis.

Professional guidelines

PubMed

Ansari AM, Osmani L, Matsangos AE, Li QK
Pathol Res Pract 2017 Oct;213(10):1237-1241. Epub 2017 Sep 1 doi: 10.1016/j.prp.2017.08.013. PMID: 28935176
Weidner T, Illing T, Elsner P
Am J Clin Dermatol 2017 Oct;18(5):629-642. doi: 10.1007/s40257-017-0278-9. PMID: 28342017
Al Yahya RS
Lasers Med Sci 2016 Jul;31(5):1027-35. Epub 2016 Mar 16 doi: 10.1007/s10103-016-1917-8. PMID: 26984345

Recent clinical studies

Etiology

Chen J, Yang H, Xu Z, Lu P, Yuan L, Xue Y, Xue R, Yang B
Dermatology 2022;238(2):368-376. Epub 2021 Aug 26 doi: 10.1159/000518082. PMID: 34515096Free PMC Article
Baykal C, Hurdogan O, Kobaner GB, Ekinci AP, Buyukbabani N
Turk Patoloji Derg 2022;38(1):54-59. doi: 10.5146/tjpath.2021.01530. PMID: 34514563Free PMC Article
Weidner T, Illing T, Elsner P
Am J Clin Dermatol 2017 Oct;18(5):629-642. doi: 10.1007/s40257-017-0278-9. PMID: 28342017
Qiao J, Fang H, Yao H
Orphanet J Rare Dis 2012 Dec 12;7:95. doi: 10.1186/1750-1172-7-95. PMID: 23234252Free PMC Article
Borowicz J, Gillespie M, Miller R
Skinmed 2011 Mar-Apr;9(2):96-100; quiz 101. PMID: 21548513

Diagnosis

Aung T, Noakes R, Murrell DF, Daniel BS, Kelati A
Australas J Dermatol 2023 May;64(2):e121-e124. Epub 2023 Feb 24 doi: 10.1111/ajd.14012. PMID: 36825814
Chen J, Yang H, Xu Z, Lu P, Yuan L, Xue Y, Xue R, Yang B
Dermatology 2022;238(2):368-376. Epub 2021 Aug 26 doi: 10.1159/000518082. PMID: 34515096Free PMC Article
Cestari TF, Dantas LP, Boza JC
An Bras Dermatol 2014 Jan-Feb;89(1):11-25. doi: 10.1590/abd1806-4841.20142353. PMID: 24626644Free PMC Article
Borowicz J, Gillespie M, Miller R
Skinmed 2011 Mar-Apr;9(2):96-100; quiz 101. PMID: 21548513
Breathnach SM
J Am Acad Dermatol 1988 Jan;18(1 Pt 1):1-16. doi: 10.1016/s0190-9622(88)70001-8. PMID: 3279077

Therapy

Weidner T, Illing T, Elsner P
Am J Clin Dermatol 2017 Oct;18(5):629-642. doi: 10.1007/s40257-017-0278-9. PMID: 28342017
Al Yahya RS
Lasers Med Sci 2016 Jul;31(5):1027-35. Epub 2016 Mar 16 doi: 10.1007/s10103-016-1917-8. PMID: 26984345
Borowicz J, Shama L, Miller R
Skinmed 2011 Sep-Oct;9(5):316-8. PMID: 22165048
Tey HL, Yosipovitch G
Acta Derm Venereol 2010 May;90(3):227-34. doi: 10.2340/00015555-0867. PMID: 20526537
Breathnach SM
J Am Acad Dermatol 1988 Jan;18(1 Pt 1):1-16. doi: 10.1016/s0190-9622(88)70001-8. PMID: 3279077

Prognosis

Andrei M, Wang JC
Hematol Oncol Stem Cell Ther 2019 Jun;12(2):71-81. Epub 2018 Sep 21 doi: 10.1016/j.hemonc.2018.09.003. PMID: 30261180
Kaltoft B, Schmidt G, Lauritzen AF, Gimsing P
Dan Med J 2013 Nov;60(11):A4727. PMID: 24192243
Borowicz J, Shama L, Miller R
Skinmed 2011 Sep-Oct;9(5):316-8. PMID: 22165048
Lee CS, Lim HW
Dermatol Clin 2003 Oct;21(4):669-77. doi: 10.1016/s0733-8635(03)00078-0. PMID: 14717407
Breathnach SM
J Am Acad Dermatol 1988 Jan;18(1 Pt 1):1-16. doi: 10.1016/s0190-9622(88)70001-8. PMID: 3279077

Clinical prediction guides

Lei W, Ai-E X
Skin Res Technol 2022 May;28(3):433-438. Epub 2022 Feb 21 doi: 10.1111/srt.13143. PMID: 35188697Free PMC Article
Baykal C, Hurdogan O, Kobaner GB, Ekinci AP, Buyukbabani N
Turk Patoloji Derg 2022;38(1):54-59. doi: 10.5146/tjpath.2021.01530. PMID: 34514563Free PMC Article
Al Yahya RS
Lasers Med Sci 2016 Jul;31(5):1027-35. Epub 2016 Mar 16 doi: 10.1007/s10103-016-1917-8. PMID: 26984345
Qiao J, Fang H, Yao H
Orphanet J Rare Dis 2012 Dec 12;7:95. doi: 10.1186/1750-1172-7-95. PMID: 23234252Free PMC Article
Wenson SF, Jessup CJ, Johnson MM, Cohen LM, Mahmoodi M
J Cutan Pathol 2012 Feb;39(2):263-9. Epub 2011 Nov 12 doi: 10.1111/j.1600-0560.2011.01812.x. PMID: 22077601

Recent systematic reviews

Alhawas F, Obaid SB, Alfawzan O, Fathaddin A, Alsuwaidan S, Alajlan A
J Cutan Pathol 2024 May;51(5):393-397. Epub 2024 Feb 8 doi: 10.1111/cup.14592. PMID: 38328942
Ahramiyanpour N, Akbari Z, Sarasyabi MS, Aflatoonian M, Saki N, Shafie'ei M
Lasers Med Sci 2022 Mar;37(2):799-813. Epub 2021 Oct 6 doi: 10.1007/s10103-021-03429-4. PMID: 34611800
Andrei M, Wang JC
Hematol Oncol Stem Cell Ther 2019 Jun;12(2):71-81. Epub 2018 Sep 21 doi: 10.1016/j.hemonc.2018.09.003. PMID: 30261180
Weidner T, Illing T, Elsner P
Am J Clin Dermatol 2017 Oct;18(5):629-642. doi: 10.1007/s40257-017-0278-9. PMID: 28342017
Kaltoft B, Schmidt G, Lauritzen AF, Gimsing P
Dan Med J 2013 Nov;60(11):A4727. PMID: 24192243

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...